As at 30 September 2024, the Trust had achieved an average annual return of 13.3% after all fees and including the reinvestment of any distributions, since its commencement on 2 March 2010.

Below is a summary of the annual percentage change in the unit price of the Lead Class units in the Trust (after all fees), against the Benchmark and the All Ordinaries Accumulation Index (Index). Note, 2010 is from the commencement of the Trust in March 2010.

Financial Year Trust Benchmark Index
2010 5.6  3.2  (7.3)
2011 10.1  10.0  12.2 
2012 18.5  10.0  (7.0)
2013 30.4  10.0  20.7 
2014 (10.8) 10.0  17.6 
2015 36.9  10.0  5.7 
2016 36.7  10.0  2.0 
2017 19.6  10.0  13.1 
2018 15.4  10.0  13.7 
2019 28.8  10.0  11.0 
2020 55.6  10.0  (7.2)
2021 69.7  10.0  30.2 
2022 (70.9)  10.0  (7.4) 
2023 19.7  10.0  14.8 
2024 39.4  10.0  12.5 
Q1'2025 (11.8)  2.5  7.9 
 
Average annual change 13.3  10.0  8.5 


This performance has been achieved through BSC’s original and considered approach toward:
    *  Patient allocation of capital;
    *  Manager (BSC) remuneration; and most importantly,
    *  The alignment of interests between the Manager and the underlying investors of the Trust.


Please note, past performance is not an indicator of future performance.

Hit the button below to keep updated.